Appears On
Episode Appearances
The Ezra Klein Show · May 8, 2026
GLP-1s and the ‘Wild West’ of Wellness
“Co-author of 'Food Intelligence'; extensively reported on GLP-1 drugs, conducted surveys and interviews with patients/doctors”
GLP-1 receptor agonists (semaglutide, tirzepatide, retatrutide) mechanisms and efficacyWeight loss as appetite suppression vs. metabolism increaseCardiovascular and organ-protective benefits independent of weight loss
View Analysis